About this trial
Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-person visits to MSK. MSK is trying to do this through a new option called enhanced telehealth.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with breast or prostate cancer at Memorial Sloan Kettering Cancer Center who have had at least 3 prior medical oncology visits.
Disqualifiers
Patient is enrolled on a therapeutic clinical trial.
Patients whose primary language is not currently supported by Epic.
Trial design
Parallel
Treatments tested in this trial
Usual practice pattern (UPP)
Other interventionPatient follows usual practice pattern for routine care
Experimental: Enhanced Telehealth (ET)
Other interventionPatient follows enhanced telehealth practice pattern. As clinically appropriate, patients given option to shift routine care from face-to-face to at-home services available at institution: telehealth visits, home phlebotomy, and educational support for home administration of injection medications
Treatment groups
Trial outcomes
Primary outcomes
Proportion of routine face to face medical oncology related visits out of total medical oncology related visits
all patients who meet eligibility criteria and have completed at least 2 medical oncology visits during the 12 month follow up period will be included for endpoint evaluability during analyses
Sponsors and contacts
Click on the lead sponsor to view all of their trials.